YQ23

BIOLOGICAL3 trials

Sponsors

New Beta Innovation Limited

Conditions

Advanced Solid TumorCritical Limb IschemiaHealthy Volunteers

Phase 1

First-In-Man, Healthy Volunteer Study to Evaluate Safety on the Use of YQ23

CompletedNCT03802292

New Beta Innovation LimitedHealthy Volunteers

Start: 2019-01-16End: 2020-11-20Updated: 2021-03-03

A Safety Study of YQ23 in Advanced Solid Tumors Patients

TerminatedNCT04513067

New Beta Innovation LimitedAdvanced Solid Tumor

Start: 2020-08-21End: 2023-07-26Updated: 2023-12-08

YQ23 Study in Patients With Critical Limb Ischaemia

TerminatedNCT04792008

New Beta Innovation LimitedCritical Limb Ischemia

Start: 2021-03-10End: 2023-08-31Updated: 2023-12-08